Literature DB >> 31454073

Meta-analysis of recurrence pattern after resection for pancreatic cancer.

M Tanaka1, A L Mihaljevic1, P Probst1, M Heckler1, U Klaiber1, U Heger1, M W Büchler1, T Hackert1.   

Abstract

BACKGROUND: Initial recurrence mapping of resected pancreatic ductal adenocarcinoma (PDAC) could help in stratifying patient subpopulations for optimal postoperative follow-up. The aim of this systematic review and meta-analysis was to investigate the initial recurrence patterns of PDAC and to correlate them with clinicopathological factors.
METHODS: MEDLINE and Web of Science databases were searched systematically for studies reporting first recurrence patterns after PDAC resection. Data were extracted from the studies selected for inclusion. Pooled odds ratios (ORs) and 95 per cent confidence intervals were calculated to determine the clinicopathological factors related to the recurrence sites. The weighted average of median overall survival was calculated.
RESULTS: Eighty-nine studies with 17 313 patients undergoing PDAC resection were included. The weighted median rates of initial recurrence were 20·8 per cent for locoregional sites, 26·5 per cent for liver, 11·4 per cent for lung and 13·5 per cent for peritoneal dissemination. The weighted median overall survival times were 19·8 months for locoregional recurrence, 15·0 months for liver recurrence, 30·4 months for lung recurrence and 14·1 months for peritoneal dissemination. Meta-analysis revealed that R1 (direct) resection (OR 2·21, 95 per cent c.i. 1·12 to 4·35), perineural invasion (OR 5·19, 2·79 to 9·64) and positive peritoneal lavage cytology (OR 5·29, 3·03 to 9·25) were significantly associated with peritoneal dissemination as initial recurrence site. Low grade of tumour differentiation was significantly associated with liver recurrence (OR 4·15, 1·71 to 10·07).
CONCLUSION: Risk factors for recurrence patterns after surgery could be considered for specific surveillance and treatments for patients with pancreatic cancer.
© 2019 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Year:  2019        PMID: 31454073     DOI: 10.1002/bjs.11295

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  25 in total

1.  Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer.

Authors:  Fabio Ausania; Santiago Sanchez-Cabus; Paula Senra Del Rio; Alex Borin; Juan Ramon Ayuso; Pilar Bodenlle; Sofia Espinoza; Miriam Cuatrecasas; Carlos Conill; Tamara Saurí; Joana Ferrer; Josep Fuster; Juan Carlos García-Valdecasas; Reyes Melendez; Constantino Fondevila
Journal:  Langenbecks Arch Surg       Date:  2021-01-21       Impact factor: 3.445

2.  Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms: A Single-Center Retrospective Study.

Authors:  Koki Hayashi; Yoshihiro Ono; Manabu Takamatsu; Atsushi Oba; Hiromichi Ito; Takafumi Sato; Yosuke Inoue; Akio Saiura; Yu Takahashi
Journal:  Ann Surg Oncol       Date:  2022-03-01       Impact factor: 5.344

Review 3.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

4.  The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion.

Authors:  Hidemasa Kubo; Katsuhisa Ohgi; Teiichi Sugiura; Ryo Ashida; Mihoko Yamada; Shimpei Otsuka; Kentaro Yamazaki; Akiko Todaka; Keiko Sasaki; Katsuhiko Uesaka
Journal:  Ann Surg Oncol       Date:  2022-04-03       Impact factor: 5.344

5.  A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer.

Authors:  Lingming Kong; Peng Liu; Xiang Fei; Tianyu Wu; Zhongpeng Wang; Baohui Zhang; Jiatong Li; Xiaodong Tan
Journal:  Front Oncol       Date:  2020-08-25       Impact factor: 6.244

6.  Heterogeneity in neoadjuvant therapy for localized pancreatic cancer: a persisting radiant autonomy.

Authors:  Kjetil Søreide
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 7.293

7.  Late recurrences of pancreatic cancer in patients with long-term survival after pancreaticoduodenectomy.

Authors:  Andreas Minh Luu; Orlin Belyaev; Philipp Höhn; Michael Praktiknjo; Monika Janot; Waldemar Uhl; Chris Braumann
Journal:  J Gastrointest Oncol       Date:  2021-04

8.  Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.

Authors:  Ido Wolf; Tami Rubinek; Shani Journo; Anat Klein Goldberg; Ethan S Sokol; Lotem Zinger; Metsada Pasmanik-Chor; Boris Sarvin; Dor Simkin; Sivan Fuchs; Tomer Shlomi
Journal:  Oncogene       Date:  2022-01-22       Impact factor: 8.756

9.  A Novel Validated Recurrence Stratification System Based on 18F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic Cancer.

Authors:  Miaoyan Wei; Bingxin Gu; Shaoli Song; Bo Zhang; Wei Wang; Jin Xu; Xianjun Yu; Si Shi
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

10.  Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectability Definition.

Authors:  Louisa Bolm; Katharina Mueller; Katharina May; Stefan Sondermann; Ekaterina Petrova; Hryhoriy Lapshyn; Kim Christin Honselmann; Dirk Bausch; Sergii Zemskov; Peter Bronsert; Tobias Keck; Steffen Deichmann; Ulrich F Wellner
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.